Low-Carb Longevity May Depend on Your Protein Source

For low-carb eaters, the most consequential question may be what replaces the carbohydrates. In a dose-response meta-analysis of 10 prospective cohorts totaling 421,022 people, dietary patterns that emphasized plant protein, non-starchy vegetables, and plant fats were associated with lower all-cause mortality. Animal-based low-carb patterns were not significantly associated with all-cause mortality, but they were associated with higher cancer mortality.

That does not prove that swapping steak for lentils extends a life. The mortality evidence is observational, rated low certainty, and highly inconsistent across cohorts. Still, the distinction matters: "low carb" describes a macronutrient ratio, not the foods that create it.

The mortality signal changes when the food sources change

Ghorbani et al.'s 2023 systematic review and dose-response meta-analysis pooled 10 prospective cohort studies. A higher plant-based low-carbohydrate diet score was associated with a 13% lower relative risk of all-cause mortality (hazard ratio [HR] 0.87; 95% confidence interval [CI], 0.78–0.97). The association was linear across the scoring range: progressively more plant-predominant low-carb eating tracked with progressively lower mortality risk, with no identified threshold.

The corresponding animal-based low-carb score had an HR of 1.08 for all-cause mortality (95% CI, 0.97–1.21). Because that interval crosses 1.0, the result was not statistically significant. It should not be recast as proof that animal-based low-carb diets raise overall mortality.

Cancer mortality told a less reassuring story. Overall low-carb scores were associated with higher cancer mortality in a linear dose-response analysis (HR 1.14; 95% CI, 1.05–1.24), and animal-based low-carb scores showed a similar association (HR 1.16; 95% CI, 1.02–1.31). Plant-based low-carb scores had no significant association with cancer mortality. These are relative associations; the analysis does not provide an absolute number of cancer deaths attributable to any dietary pattern.

The same review found a U-shaped association between overall low-carb eating and both all-cause and cardiovascular mortality, with the lowest estimated risk at moderate carbohydrate intake. That result is a warning against treating carbohydrate reduction as a one-dimensional optimization problem.

Cardiovascular markers support the food-quality explanation

The mortality results fit with a broader, though still imperfect, cardiovascular evidence base. Landry et al.'s 2024 umbrella review concluded that vegetarian dietary patterns are consistently associated with lower LDL cholesterol, lower blood pressure, lower C-reactive protein, and better endothelial function than omnivorous comparators. These are risk factors and biomarkers, not proof of fewer heart attacks or longer survival, but they offer plausible routes by which food substitutions could matter.

A 2023 meta-analysis of prospective cohorts by Dybvik et al. found that vegetarian and vegan diets were associated with lower ischemic heart disease risk. Associations with total cardiovascular disease and stroke were less clear. That distinction matters because the Ghorbani analysis found no significant association between any low-carb pattern—plant-based, animal-based, or overall—and cardiovascular mortality.

Risk-factor improvement and lower cardiovascular mortality are related hypotheses, not interchangeable outcomes. Mortality takes longer to observe, requires more events, and can be affected by factors beyond LDL cholesterol or blood pressure. Or the marker improvements may simply fail to translate into a detectable mortality difference within the available cohorts.

Substitution studies point in the same direction

The cleaner dietary question is often substitution: what happens when one food replaces another at the same calorie intake? Zheng et al.'s 2022 systematic review found that calorie-for-calorie replacement of animal protein with plant protein was associated with better cardiometabolic markers, cardiovascular outcomes, and mortality-related outcomes across aging research. It strengthens the case that protein source matters, although the review does not turn the long-term mortality association into a randomized causal finding.

Controlled evidence also supports a lipid effect in a specific clinical group. Papaodyssea et al.'s 2025 meta-analysis of controlled trials in people with chronic kidney disease found that greater plant-protein intake improved total cholesterol and LDL cholesterol versus animal protein at equivalent intake. Chronic kidney disease limits how directly that result applies to healthy adults, but it is stronger evidence for a lipid outcome than an observational diet questionnaire can provide.

Food-specific evidence narrows one likely concern. A 2023 dose-response meta-analysis by Wu et al. associated higher red and processed meat intake with greater cardiovascular and cancer mortality. It does not show that all animal protein has the same effect, and it cannot identify which component of an animal-based low-carb score drives the cancer association. But it makes red and processed meat a more evidence-based target than animal protein as a single category.

Why the conclusion must stay cautious

The pooled estimates in Ghorbani et al. came with extreme heterogeneity: I² values ranged from 73% to 88% across major mortality analyses. In practical terms, the cohort results varied enough that the pooled HR is a rough average, not a universal forecast. The authors rated the evidence low certainty.

Observational cohorts also cannot fully separate diet from the people who choose it. Plant-predominant eaters may differ in income, exercise, medical care, smoking, baseline illness, and other health behaviors. Statistical adjustment helps, but it cannot measure every relevant difference perfectly. Most cohorts assessed diet once at baseline, which can also misclassify years of dietary change.

Independent studies do not all reproduce the pattern. A 2025 NHANES III analysis by Papanikolaou et al. found null associations of both animal and plant protein intake with all-cause, cardiovascular, and cancer mortality. Its exposure was protein source rather than a composite low-carb dietary score, so it was not testing precisely the same question. Still, it is a meaningful contradiction, not a footnote.

Likewise, Das et al.'s prospective study of older Australian men found attenuated or null associations between protein source and mortality. Age, sex, geography, baseline disease risk, and adherence duration could all modify dietary associations; the available analyses did not formally resolve those possibilities.

Long-term randomized trials comparing plant-based and animal-based low-carb diets on mortality do not exist. The current evidence can rank probabilities, not assign destiny.

The highest-rigor synthesis makes the same point. A 2021 Cochrane review of vegan diets for cardiovascular prevention rated the evidence for clinical cardiovascular outcomes as low to very low certainty. That assessment should prevent anyone from selling plant-based eating as a guaranteed cardiovascular intervention.

A practical low-carb interpretation

If you prefer a low-carbohydrate diet, the evidence favors improving the sources of protein and fat rather than chasing a lower carbohydrate number. Build meals around legumes where they fit your carbohydrate target, nuts, seeds, non-starchy vegetables, and plant oils. Reduce red and processed meat, especially when it supplies much of the diet's protein and fat.

Plant-based does not mean automatically protective. Landry et al. notes that vegetarian diets high in refined carbohydrates, added sugars, or saturated fat may not deliver the same cardiovascular advantages. Sweetened plant drinks and ultra-processed meat analogs do not inherit the benefits of legumes merely by sharing a grocery aisle.

The best-supported conclusion is modest but useful: among low-carb dietary patterns, a larger plant-food component is associated with lower all-cause mortality, while animal-heavy versions carry a statistically significant cancer-mortality association in the largest cited meta-analysis. The evidence cannot prove cause and effect. It does give low-carb eaters a rational reason to care about the ingredients behind the macros.